Addiction

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
Sarah Larney, Matthew Hickman, David A Fiellin, Timothy Dobbins, Suzanne Nielsen, Nicola R Jones, Richard P Mattick, Robert Ali, Louisa Degenhardt

BMJ Open Aug 2018, 8 (8) e025204; DOI: 10.1136/bmjopen-2018-025204
Does providing a brief internet intervention for hazardous alcohol use to people seeking online help for depression reduce both alcohol use and depression symptoms among participants with these co-occurring disorders? Study protocol for a randomised controlled trial
John A Cunningham, Christian S Hendershot, Frances Kay-Lambkin, Clayton Neighbors, Kathleen M Griffiths, Kylie Bennett, Anthony Bennett, Alexandra Godinho, Christina Schell

BMJ Open Jul 2018, 8 (7) e022412; DOI: 10.1136/bmjopen-2018-022412
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
Nadine Ezard, Adrian Dunlop, Michelle Hall, Robert Ali, Rebecca McKetin, Raimondo Bruno, Nghi Phung, Andrew Carr, Jason White, Brendan Clifford, Zhixin Liu, Marian Shanahan, Kate Dolan, Amanda L Baker, Nicholas Lintzeris

BMJ Open Jul 2018, 8 (7) e020723; DOI: 10.1136/bmjopen-2017-020723
Comparison of self-reported measures of alcohol-related dependence among young Swiss men: a study protocol for a cross-sectional controlled sample
Katia Iglesias, Frank Sporkert, Jean-Bernard Daeppen, Gerhard Gmel, Stephanie Baggio

BMJ Open Jul 2018, 8 (7) e023632; DOI: 10.1136/bmjopen-2018-023632
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
Kerstin K Antonsen, Mette K Klausen, Amanda S Brunchmann, Nina le Dous, Mathias E Jensen, Kamilla Woznica Miskowiak, Patrick M Fisher, Gerda K Thomsen, Henrik Rindom, Thomas P Fahmy, Sabine Vollstaedt-Klein, Helene Benveniste, Nora D Volkow, Ulrik Becker, Claus Ekstrøm, Gitte Moos Knudsen, Tina Vilsbøll, Anders Fink-Jensen

BMJ Open Jul 2018, 8 (7) e019562; DOI: 10.1136/bmjopen-2017-019562
Reducing the default dispense quantity for new opioid analgesic prescriptions: study protocol for a cluster randomised controlled trial
Marcus A Bachhuber, Denis Nash, William N Southern, Moonseong Heo, Matthew Berger, Mark Schepis, Chinazo O Cunningham

BMJ Open Apr 2018, 8 (4) e019559; DOI: 10.1136/bmjopen-2017-019559
Piloting the addition of contingency management to best practice counselling as an adjunct treatment for rural and remote disordered gamblers: study protocol
Darren R Christensen, Chad S G Witcher, Trent Leighton, Rebecca Hudson-Breen, Samuel Ofori-Dei

BMJ Open Apr 2018, 8 (4) e018804; DOI: 10.1136/bmjopen-2017-018804
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
Amy Peacock, Briony Larance, Michael Farrell, Rose Cairns, Nicholas Buckley, Louisa Degenhardt

BMJ Open Mar 2018, 8 (3) e020006; DOI: 10.1136/bmjopen-2017-020006
Management and Point-of-Care for Tobacco Dependence (PROMPT): a feasibility mixed methods community-based participatory action research project in Ottawa, Canada
Smita Pakhale, Tina Kaur, Catherine Charron, Kelly Florence, Tiffany Rose, Sadia Jama, Robert Boyd, Joanne Haddad, Gonzalo Alvarez, Mark Tyndall

BMJ Open Jan 2018, 8 (1) e018416; DOI: 10.1136/bmjopen-2017-018416
What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care
Albert Stuart Reece, Gary Kenneth Hulse

BMJ Open Jan 2018, 8 (1) e016806; DOI: 10.1136/bmjopen-2017-016806

Main menu

Addiction

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Addiction

Pages